Korro Bio (KRRO) Stock Analysis: AI Score & Alternative Data
KRRO alt-data: headcount climbing, web traffic lagging
Is Korro Bio a buy right now? The alternative data says hold. This KRRO stock analysis is built on the 25+ alternative data signals AltIndex tracks on Korro Bio every day — hiring, web traffic, sentiment, social reach — rolled into an AI Score of 52/100: a Hold. The stock trades at $10.16 with a $150M market cap.
The bullish side of the 90-day ledger: headcount (according to LinkedIn) up 5.4% to 78 employees. The drag: web traffic down 35.0% to 4K monthly visits, job postings down 16.7% to 5 open roles, and just 51% of employees report a positive business outlook. That tension is what keeps the score mid-range.
KRRO’s broader alt-data profile also covers X followers (523), and sentiment (100/100). Every signal links to its own page with full history, the KRRO technical analysis covers RSI, moving averages, and support and resistance, and the full table of everything AltIndex tracks on KRRO is just below.
Korro Bio AI Stock Analysis
Korro Bio is a biotechnology company specializing in the development of RNA-targeted therapeutics. The company leverages its expertise in RNA editing to provide novel treatment options for patients with unmet medical needs.
Analysis generated October 4, 2026.
Recent Korro Bio Stock Alerts
|
Korro Bio | October 7 Price is up by 7.2% in the last 24h. |
|
Korro Bio | September 11 Price is up by 6.7% in the last 24h. |
|
Korro Bio | September 8 Price is up by 6.2% in the last 24h. |
|
Korro Bio | August 30 Insider Alert: FORMELA JEAN FRANCOIS is selling shares |
Korro Bio Alternative Data
| Alternative Data | Value | 3m Change | Trend |
|---|---|---|---|
| Webpage Traffic | 4K | 35.0% | |
| Job Posts | 5 | 16.7% | |
| LinkedIn Employees | 78 | 5.4% | |
| Employee Recommend | 67 | 8.1% | |
| Business Outlook | 51 | 0% | |
| Sentiment | 100 | 0% | |
| Reddit Mentions | 0 | N/A | |
| X Mentions | 1 | 0% | |
| Stocktwits Mentions | 3 | 200.0% | |
| News Mentions | 0 | N/A | |
| Stocktwits Subscribers | 3K | 0% | |
| 4chan Mentions | 0 | N/A | |
| X Followers | 523 | 0.6% |
About Korro Bio (KRRO)
Korro Bio, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of genetic medicines based on editing RNA for the treatment of rare and highly prevalent diseases primarily in the United States.
| Price | $10.16 |
| Target Price | $387.74 |
| Volume | 63,420,177 |
| Market Cap | $150M |
| Year Range | $5 – $49 |
| Dividend Yield | 0% |
| PE Ratio | — |
| Analyst Rating | 38% buy |
| Industry | Biotechnology |
Latest Korro Bio News
View more →
Korro Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)July 10 - GlobeNewswire |
|
Korro Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)May 15 - GlobeNewswire |
|
Clear Street Upgrades Korro Bio to Buy, Raises Price Target to $18February 18 - Benzinga |
|
William Blair Upgrades Korro Bio to OutperformFebruary 16 - Benzinga |
|
See Korro Bio’s complete price and AI Score history
Sign up to unlock 1-year and all-time charts for KRRO, plus 25+ alternative data signals, AI Scores, and real-time alerts.
Get Started for FREEKorro Bio Earnings & Financial Performance
View all earnings →Korro Bio Insider Trading Activity
View all →| FORMELA JEAN FRANCOIS filed to sell 132,650 shares at $0.0. Sep 14 '26 |
| FORMELA JEAN FRANCOIS filed to sell 640,610 shares at $0.0. Sep 14 '26 |
| Dolan Oliver filed to sell 16,241 shares at $0.0. Sep 11 '26 |
| FORMELA JEAN FRANCOIS filed to sell 139,252 shares at $0.0. Sep 11 '26 |
| FORMELA JEAN FRANCOIS filed to sell 672,498 shares at $0.0. Sep 11 '26 |
Korro Bio Congress Trading
View all →| Politician | Filing Date | Type | Size |
|---|---|---|---|
| No congress trades on file. | |||
Stocks Similar to Korro Bio
See all →| Company | Price | Market Cap | AI Score | |
|---|---|---|---|---|
 |
CodexisCDXS |
$1.41 3.7% | $149M | 47 |
 |
Molecular PartnersMOLN |
$3.85 1.1% | $147M | 52 |
 |
Assertio TherapeuticsASRT |
$23.50 0.1% | $152M | 40 |
 |
Acumen PharmaceuticalsABOS |
$2.14 1.9% | $152M | 54 |
 |
Voyager TherapeuticsVYGR |
$2.45 3.4% | $146M | 42 |
Explore Korro Bio Data
Frequently Asked Questions: Korro Bio (KRRO)
Korro Bio has an AltIndex AI Score of 52/100 (Hold). The score reflects mixed alternative data signals. All investments carry risk.
52/100. The AI Score combines 25+ alternative data signals including job postings, employee sentiment, social media, web traffic, and financials. Scores above 60 = buy, 40–59 = hold, below 40 = sell. Updated daily.
Currently, the price of one share of Korro Bio (KRRO) stock is $10.16 with a market cap of $150M.
As of today, Korro Bio’s PE (Price to Earnings) ratio is —.
View the latest Korro Bio insider transactions to see recent buying and selling activity by company executives and directors.
Check the Korro Bio congress trading page for the latest disclosed trades by U.S. senators and representatives.
AltIndex tracks 25+ signals including job postings, web traffic, employee sentiment, Reddit mentions, Stocktwits activity, insider transactions, congressional trades, Google Trends, app downloads, and more.
The KRRO stock price chart above shows Korro Bio’s performance over time alongside its AI Score. Investors can identify patterns, trends, and potential support or resistance levels. View the full Korro Bio technical analysis for RSI, moving averages, and more.
See the stocks similar to Korro Bio section on this page for companies in the same industry ranked by market cap and AI Score.
